Research Project
Grant-in-Aid for Young Scientists (B)
The heterogeneity of blood flow and the hypoxia in tumor have been reported to be associated with malignant potential and metastatic potential of malignat neoplasms. Contrast enhancement ultrasonography is able to assess the blood flow in tumor. It might be easily able to evaluate the malignant potential of tumor. We found that the blood flow in tumor bacame homogenous when drug therapy had good response for tumor.We analyzed the association between pathological background of breast cancer and blood flow in tumor using contrast enhanced ultrasonography. It had been found that breast cancer witout estrogen receptor more frequently had the heterogeneity of blood flow in tumor. The expression of estrogen receptor is target for endocrine therapy. It was suggested that endocrine therapy might not be usuful for breast tumor with heterogeneity of blood flow.
All 2017 2016
All Presentation (10 results) (of which Int'l Joint Research: 2 results)
